Showing results (2621-2630 of 25,162) with videos related to

Sort By:
Pageof 2,517
Oncotarget|July 19, 2018
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibitionSa Rang Kim, Julia M Lewis, Benoit M Cyrenne, et al.
Oncotarget|July 19, 2018
Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapyArtem Blagodatski, Margarita Yatsunskaya, Valeriia Mikhailova, et al.
Oncotarget|July 11, 2018
Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT)Connie H M Ho, Chi-Leung Chiang, Francis A S Lee, et al.
Oncotarget|July 11, 2018
EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indicationSami Sebastian Khaznadar, Martin Khan, Elke Schmid, et al.
Oncotarget|July 11, 2018
Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitorsIshwaria M Subbiah, Chad Tang, Arvind Rao, et al.
Oncotarget|July 11, 2018
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genesElsa Maitre, Philippe Bertrand, Catherine Maingonnat, et al.
Oncotarget|June 23, 2018
Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: a single center experience and recommendationLi Li, Yi Li, Jun Zhang, et al.
Oncotarget|June 23, 2018
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)Dominique Farge, Francis Cajfinger, Nicolas Falvo, et al.
Oncotarget|June 23, 2018
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitorsMeriem Sarah Mekki, Alexandra Mougel, Audrey Vinchent, et al.
Oncotarget|June 23, 2018
Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancerTeresa Morán, Eudald Felip, Joaquim Bosch-Barrera, et al.
Pageof 2,517